Provectus Pharmaceuticals, Inc. (OTCBB:PVCT), a development-stage oncology and dermatology biopharmaceutical company, has added Mount Sinai School of Medicine as its second and final site for its expanded Phase 2 clinical trial of the Company's lead dermatology agent PH-10 for psoriasis. Jason Emer, M.D...

Title: New Osteoporosis Drug Coming?
Category: Health News
Created: 8/11/2009
Last Editorial Review: 8/11/2009

Title: New Bone-Building Drug Promising Against Prostate Cancer
Category: Health News
Created: 8/11/2009 10:18:00 AM
Last Editorial Review: 8/11/2009

Eczema is a chronic skin disorder characterized by dry, itchy, scaly skin and rashes. It is commonly known as "the itch that rashes." (1) While the exact cause of eczema is not known, it appears to result from a complex interaction of factors including personal and family genetics, immune response and environmental factors. (2) Scratching the affected area can lead to more itch, redness, swelling, scaling, cracking, oozing clear fluid and, ultimately, crusting.